Members of the mammalian ATF/CREB family of transcription factors, which are associated with regulation by cyclic AMP and viral oncogenes, bind common DNA sequences (consensus TGACGTCA) via a bZIP domain. 
specific DNA binding to an ATF/CREB site. Within the bZIP domain, ACR1 most strongly resembles the mammalian cyclic AMP-responsive transcriptional regulators CREB and CREM; it is less similar to GCN4 and YAP1, two previously described yeast bZIP transcriptional activators that recognize the related AP-1 sequence (consensus TGACTCA). Interestingly, deletion of the ACRI gene causes increased transcription through ATF/CREB sites that does not depend on GCN4 or YAP1. Moreover, extracts from acri deletion strains contain one or more ATF/CREB-like DNA-binding activities. These genetic and biochemical observations suggest that S. cerevisiae contains a family of ATF/CREB proteins that function as transcriptional repressors or activators.
ATF/CREB proteins are defined by their ability to bind specifically to DNA sequences (consensus TGACGTCA) found in numerous eukaryotic promoters (15, 17, 18, 22) . These proteins bind as dimers to abutting half-sites by using a conserved bZIP structural motif, which consists of a leucine zipper dimerization element and an adjacent basic region that interacts directly with DNA (29) . ATF/CREB proteins are structurally and functionally related to the AP-1 family of eukaryotic transcription factors, which includes the Jun and Fos oncoproteins and yeast GCN4 and YAP1 (2, 9, 10, 34, 50) . ATF/CREB sequences contain the same half-sites as AP-1 sequences but differ in spacing by an additional base pair in the center of the sequence (42) . In general, AP-1 proteins efficiently recognize ATF/CREB sites, whereas ATF/CREB proteins bind inefficiently to AP-1 sites (17, 42) . Individual AP-1 and ATF/CREB proteins have distinct dimerization properties, and interactions within and between these families generate a large number of potential transcriptional regulatory proteins (16) .
In mammalian cells, ATF/CREB sites are often associated with transcriptional regulation by cyclic AMP (cAMP) or by the adenovirus ElA transforming gene (17, 40) . The mammalian ATF/CREB family contains at least 10 proteins that have well conserved but individually distinct bZIP domains (13, 15, 18, 22, 32, 57) . Of these, CREB, CREM, and ATF-2 are the only ATF/CREB proteins with defined biological functions. Specifically, CREB stimulates transcription in response to cAMP and calcium in a phosphorylation-dependent manner (14, 43) , CREM functionally counteracts the activity of CREB (12) , and ATF-2 is responsible for mediating adenovirus ElA-dependent transactivation (31) .
ATF/CREB DNA-binding activities distinct from those of GCN4 have been detected in cell extracts from the yeast Saccharomyces cerevisiae. First, a 66-kDa ATF/CREB binding protein, whose DNase I footprinting properties are similar to those of mammalian ATF proteins, can be purified by oligo-affinity chromotography (30) . Second, a partially purified yeast ATF/CREB binding activity is phosphorylated by protein kinase A in vitro (26) , suggesting a possible link between cAMP signaling and ATF/CREB protein function. Third, chromatographically separable activities that form electrophoretically distinct protein-DNA complexes have been described (42) . Because these activities were defined by binding to nonidentical (although related) DNA sequences and were isolated by different experimental procedures, it is unclear whether they represent one or multiple ATE/CREB proteins. It is also unclear whether the chromatographically distinct DNA-binding activities represent multiple proteins or differentially modified or proteolytic products of a single factor.
When placed upstream of a CYCI or GALl TATA element, ATF/CREB recognition sequences stimulate transcription in vivo (26, 30, 42) . Although a single ATF/CREB site activates transcription very poorly, two or three sites can stimulate transcription to the level of a typical yeast promoter. In contrast, substitution of an ATF/CREB sequence in place of the GCN4 binding site in the wild-type his3 promoter causes a significant decrease in basal his3 transcription (42) . Although GCN4 efficiently binds the ATF/CREB element in vitro and activates transcription through this sequence in vivo, the observed repression does not depend on GCN4 and hence presumably involves an ATF-CREB repressor. Moreover, the putative repressor appears to compete with GCN4 for binding to the ATF/ CREB site in vivo (42) .
If a single ATF/CREB protein exists in S. cerevisiae, then activation or repression could result from differences in the promoter context of the ATF/CREB recognition sequence, as has been observed for the transcriptional regulatory proteins RAP1 (44) and MCM1 (1, 27, 37 KY899 and KY908 mediated through ATF/CREB sites. These mutations define a new gene, ACR1, which encodes a novel ATF/CREB repressor whose bZIP domain most strongly resembles that of the mammalian transcriptional regulatory proteins CREB and CREM. Furthermore, we present genetic and biochemical evidence for additional ATF/CREB proteins, including a transcriptional activator(s) that is distinct from GCN4 and YAP1, the two previously characterized yeast bZIP family members.
MATERIALS AND METHODS
Isolation of acrl mutants. YCp86-Sc4281, a URA3 centromeric vector that contains the his3-303 promoter region fused to the lacZ structural gene and that was constructed by substituting the 775-bp BamHI-HindIII his3 promoter fragment from pUC8-Sc4281 (42) for the equivalent fragment in YCp86-Sc3416 (47), was introduced into KY898 and KY899 (42) ( Table 1) . Twenty independent colonies (10 from each of the resulting strains) were plated (2 x 104 cells per plate) on glucose minimal medium supplemented with appropriate amino acids and 40 mM aminotriazole (AT). Colonies growing on AT were replica plated on medium containing 5-bromo-4-chloro-3-indolyl-,-D-galactopyranoside (X-Gal) (40 mg/liter), and blue, AT-resistant colonies were selected for further analysis. In crosses between a total of 52 mutants and the appropriate starting strain, all of the diploids displayed a codominant phenotype, as determined by both AT sensitivity and lacZ activity. Nine mutant strains that appeared to be recessive had a very weak AT-resistant phenotype and were not studied further.
Cloning of ACRI. KY900 was transformed by YCp87-Sc4281, a molecule generated by inserting the BamHIHindIII fragment containing the his3-303 promoter into a LEU2 derivative of YCp86-Sc3416 (constructed by Joan Sellers). The resulting strain (KY901) was (46) . The resulting molecule was cleaved with ClaI and integrated into KY899 through homologous recombination. The resulting strain was crossed with an acrl strain (KY900), and the diploids were subjected to tetrad analysis.
DNA manipulations. YCp315-ACR1 contains a 9.3-kb PstIBamHI fragment in pRS315 (46) . The following molecules are derivatives of YCp315-ACR1 (see Fig. 2 centrally positioned ATF/CREB site (ATGACGTCAT), and DNA-binding assays were performed as described previously (23) . To assay for yeast ATF/CREB DNA-binding activities, we prepared a cell extract from an acrl::URA3 strain (KY908) and fractionated it by heparin-agarose chromatography as described previously (42) . DNA-binding assays were performed as described previously (42) (42) . Moreover, the level of GCN4-activated transcription in his3-303 strains was reduced, presumably because of competition between GCN4 and the putative repressor for the ATF/CREB sequence. Thus, mutations in the gene encoding the putative ATF/CREB repressor should increase transcription from the his3-303 promoter under normal growth conditions and during amino acid starvation.
To isolate such mutations, we started with isogenic a and a strains that carry a chromosomal copy of the his3-303 allele (KY898 and KY899) and a centromeric plasmid containing the identical promoter fused to a his3-lacZ structural gene (YCp86-Sc4906). Because of the relatively low activity of the his3-303 promoter, these strains grew poorly in the presence of 40 mM AT, a competitive inhibitor of the his3 gene product, and were white on X-Gal indicator plates. Thus, derivatives of the starting strains were selected for growth at high AT concentrations and then screened for the expression of the LacZ reporter (blue colonies). We obtained 59 independently derived strains that presumably contained mutations that were unlinked to HIS3 and that increased transcription from the his3-303 promoter.
When the mutant strains were crossed with the parental strain, the resulting heterozygous diploids displayed an intermediate sensitivity to AT because the his3-303,A86 promoter displays increased his3 expression in the acrl mutant strain.
Cloning of the ACRI gene. To clone ACR1, we introduced a library of yeast genomic sequences into KY901, an acrl his3-303 strain containing the his3-303 lacZ plasmid. Of the 20,000 transformants screened, one grew poorly in 40 mM AT and was white, suggesting that it contained a plasmid that restored ACRI function. A plasmid containing 22 kb of yeast DNA was recovered from this transformant and shown to complement the acrl mutation. To verify that this DNA contained ACR1, we subcloned a 2.8-kb EcoRI-SalI fragment (Sc5051) into a TRPI integration vector and introduced it into KY899 through homologous recombination. This integration event, which had no effect on the ACRI phenotype, was confirmed by genomic hybridization (data not shown). When this strain was crossed with an acrl strain (KY900), the resulting diploids (13 of 13) showed 2:2 segregation of the TRPI marker with the AT-sensitive phenotype, indicating that the cloned DNA contained the ACRI locus.
The ACRI gene was initially localized to a 9.3-kb PstIBamHI fragment from the initial plasmid DNA. To define the ACRI gene boundaries more precisely, we generated a series of deletions and tested them in the complementation assay (Fig. 2) . Deletions encroaching from one direction do not affect ACRI function until they reach the HindIII site, whereas deletions from the other direction do not affect ACRI activity until they reach the XbaI site. Thus, ACRI is localized within a 3. (Fig. 3) . ACRI encodes a 2.7-kb RNA that is absent in a strain with a deletion of the gene. In rich medium containing glucose, galactose, ethanol, or glycerol as a source of carbon, the ACR1 transcript levels were equivalent to those of the TFIID internal control. In addition, deregulating the cAMP pathway by disruption of BCYI (which encodes the regulatory subunit of the cAMP-dependent protein kinases) or subjecting the cells to heat shock had no effect on ACRI transcription. Finally, ACRI does not appear to be autoregulated because similar RNA levels were observed in wildtype and acrl mutant strains.
ACR1 contains a bZIP domain homologous to that in mammalian ATF/CREB proteins. Sequence analysis of the ACRI gene region (Fig. 4) ably affect ACRJ function. However, conceptual translation of the ACRI locus actually reveals a potential open reading frame encoding a 741-amino-acid protein that includes an additional 94 amino acids prior to the 5'-proximal AUG codon. Although this 94-amino-acid region does not include any methionine residues, ACRI gene products larger than 647 residues could be generated in principle either by translational initiation at non-AUG codons or by initiation at a more upstream AUG codon that becomes fused to theACRI open reading frame upon RNA splicing. For reasons described above, we doubt that such larger proteins contribute significantly to ACRI function; hence, the 647-residue protein will be considered the primary translation product, although the issue has not been resolved definitively.
The most noteworthy feature of the ACRI coding sequence is the region from residues 430 to 482, which possesses all the characteristics of a bZIP DNA-binding domain (Fig. 5) (29) . The putative basic region of ACR1 contains the invariant asparagine and arginine residues, a pair of highly conserved alanines, and 5 of the 6 conserved positively charged residues (38) . ACR1 also contains a 4-3 repeat of hydrophobic amino acids that strongly resembles the leucine zipper dimerization motif (29, 35, 36) , even though only 2 leucine residues are found at position d of the coiled coil instead of the usual 4 or 5. Furthermore, the highly conserved and functionally critical spacing between the basic region and the leucine zipper (39, 54) is precisely maintained in ACR1.
When compared with other bZIP proteins (Fig. 5) , ACR1 is most similar to the mammalian CREB and CREM proteins (52% sequence identity in the basic region), which are associated with the transcriptional response to cAMP. ACR1 is less similar to YAP1, GCN4, and CYS3, the known yeast bZIP family members. As expected from previous comparisons of bZIP proteins, ACR1 shows considerably more sequence similarity in the basic region than in the leucine zipper. With regard to previously characterized ATF/CREB family members, ACR1 is unique in having an isoleucine instead of a leucine at the first position of the zipper. However, at position d of the remaining heptad repeats, the amino acids found in ACR1 can be observed in other members of the ATF/CREB family. Finally, ACR1 contains a highly conserved lysine residue (Lys-451) that is found in 11 of 12 ATF/CREB proteins but is absent in AP-1 proteins, such as GCN4, YAP1, and the Jun family.
In addition to the highly conserved bZIP region, ACR1 contains the sequence KRRMS (residues 376 to 380), which conforms to both consensus sequences (KRRXS and RRXS) for phosphorylation by cAMP-dependent protein kinases (3, 28) . Otherwise, the putative structural gene for ACR1 does not contain any other recognizable sequence motifs. In particular, the TPR (21, 45) and 1-transducin (11) motifs found, respectively, in the yeast negative regulatory proteins SSN6 (41) and TUP1 (55) are not observed.
Functional mapping of ACR1. The region of ACR1 required for repressor function was defined by N-and C-terminal deletion analysis starting with a DNA molecule in which a 4.8-kb EcoRV ACRI fragment was cloned into a yeast expression vector between the DEDI promoter and the GCN4 termination sequences (Fig. 6A) . A derivative that has a deletion of the 335 N-terminal residues of ACR1 and retains only 94 residues in front of the bZIP domain complements an acrl mutation and seems to have enhanced repressor activity with respect to the product of the wild-type gene (acrl-C312; Fig. 6B ). This apparent increase in repressor function could be the result of the increased expression or stability of the truncated protein or the removal of an N-terminal region that counteracts repressor activity (see Discussion). In any event, this observation indicates that the C-terminal 312 residues are sufficient for ACR1 function.
In contrast, the deletion of only 13 amino acids from the C terminus of the acrl-C312 gene product abolishes repressor activity, as do more extensive C-terminal deletions. This result is surprising because the extreme C terminus of the protein is located far from the bZIP domain, and it suggests the possibility of a distinct functional domain necessary for transcriptional repression. However, in the absence of antibodies to ACR1, we cannot exclude the trivial possibility that proteins with C-terminal deletions are degraded in vivo.
ACRI binds to an ATF/CREB site as a homodimer. To demonstrate that ACR1 binds DNA in a sequence-specific manner, we synthesized a variety of 35S-labeled proteins in vitro by using a DNA template encoding a derivative lacking the N-terminal 335 residues that are dispensible for function in vivo (see above). By linearizing the template at several positions with respect to the C terminus, we generated proteins of 312, 247, and 152 amino acids (Fig. 7A) . While the 152-amino-acid derivative does not bind DNA in vitro (data not shown), the two longer derivatives exhibit sequence-specific DNA binding (Fig. 7B) . In particular, both ACR1 proteins bind efficiently to a conventional ATF/CREB site (TGACGTCA), extremely poorly to a conventional AP-1 site (TGACTCA), and nondetectably to a symmetric double mutant site (TGA(iCA). Thus, ACR1 binding specificity strongly resembles that of mammalian ATF/CREB proteins.
To determine whether ACR1 binds DNA as a homodimer or as a heterodimer with a protein(s) in the wheat germ extract used for in vitro synthesis, we cotranslated the 312-and 247-residue ACR1 derivatives (Fig. 7B) (25) , the ACR1 heterodimer complex is not observed the his3-303 promoter, we examined the effect of acrl on a when the two proteins are synthesized independently and heterologous promoter containing one or two copies of an then mixed prior to the DNA-binding assay; this result identical ATF/CREB sequence upstream of thegall TATA indicates that ACR1 can form stable dimers in the absence of element and mRNA initiation region (42) . When compared DNA.
N S S B E R S R Q P S T V S T F D

TTAGAACCCAATCCTTTTGAACAAAGCTTCGCCTCTTCCAAGAAGGCTTTGTCACTTCCAGGCACGATCTCCCATCCGTCTCTACCAAAAGAGCTTTCAC L B P N P F B Q S F A S S X X A L S L P G T I S H P S L P X E L S
GAAACAATTCTACCTCAACGATAACACAACATTCCCAACGTTCCACTCATAGTTTGAACAGTATTCCAGAAGAAAATGGGAATTCAACCGTTACAGATAA R N N S T 8 T I T Q H S Q R S T H S L N S I P E B N G N S T V T D N
TAGTAATCATAATGACGTAAAAAAAGACTCACCTAGTTTTTTACCAGGCCAACAAAGACCTACTATAATATCTCCGCCTATTCTCACACCTGGTGGGTCG S N H N D V X X D S P S F L P G Q Q R P T I I S P P I L T P G G S 352 AAAAGATTACCACCTCTACTCCTTTCTCCCTCTATTTTATATCAGGCAAATTCAACTACGAATCCCAGTCAGAATTCACATTCTGTTTCAGTCTCTAATT X R L P P L L L S P S I L Y Q A N S T T N P S Q N S H S V S V S N 452 CAAACCCTAGTGCAATAGGCGTTTCTTCTACCTCCGGATCTCTGTATCCAAACAGCTCTTCTCCTTCAGGGACTTCACTTATACGCCAGCCACGAAACTC S N P 8 A I G V 8 S T S G S L Y P N S S S P S G T S L I R Q P R N S 552 GAACGTGACCACAAGTAATTCTGGTAACGGCTTCCCCACGAATGATTCACAAATGCCTGGCTTTTTATTAAACTTGTCCAAATCTGGGTTGACACCTAAT N V T T S N S G N G F P T N D S Q N P G F L L N L S X S G L T P N 652 GAGTCCAATATCAGGACCGGGTTGACACCCGGTATTCTTACGCAATCTTACAATTATCCCGTATTGCCGTCAATTAATAAAAATACTATAACAGGTAGCA B S N I R T G L T P G I L T Q S Y N Y P V L P S I N X N T I T G S
AAAATGTCAACAAAAGTGTCACAGTGAATGGAAGTATTGAAAACCACCCTCATGTTAATATAATGCACCCAACTGTAAATGGTACACCACTTACGCCGGG X N V N X S V T V N G S I B N H P H V N I N H P T V N G T P L T P G
ATTGAGTTCTCTGCTAAACTTACCATCTACTGGAGTTTTGGCTAATCCAGTATTCAAATCAACACCTACAACAAATACCACAGATGGTACCGTCAACAAC L S S L L N L P S T G V L A N P V F X S T P T T N T T D G T V N N
AGCATCAGTAATTCCAATTTTTCCCCAAATACTTCAACGAAAGCGGCTGTCAAAATGGATAATCCGGCAGAGTTCAATGCCATCGAGCACTCCGCTCATA S I S N S N F S P N T S T X A A V X N D N P A B F N A I E H S A H 1052 ATCACAAGGAGAATGAAAATTTAACGACTCAAATTGAGAACAATGACCAGTTCAATAACAAAACACGAAAAAGAAAGAGAAGGATGTCTAGCACAAGTTC N H X E N B N L T T Q I E N N D Q F N N X T R X R |X R R N SI S T S S 1152 TACTTCTAAGGCTTCAAGAAAAAATTCCATATCAAGAAAAAACTCAGCAGTTACGACTGCACCAGCACAAAAAGATGATGTTGAAAATAATAAAATTTCA T S X A S R X N S I S R X N S A V T T A P
with a wild-type strain, acrl-l strains show a 5-fold increase An ATF/CREB-like activator(s) stimulates transcription in expression through a single ATF/CREB site and a 14-fold through the ATF/CREB-like sequence. As expected from its increase through two such sites (Table 2) . Moreover, a defining phenotype, an acrl-l strain shows elevated levels of control gall promoter lacking ATF/CREB sites is inactive in his3 transcription from the his3-303 promoter (Fig. 8) . More 12 previously identified ATF/CREB proteins from other organisms as well as yeast GCN4, YAP1, and CYS3. The boxed residues within the basic region include invariant asparagine and arginine residues as well as a highly conserved pair of alanines, cysteine, serine, and three positively charged residues; within the leucine zipper the boxed residues represent the 4-3 hydrophobic repeat including the conserved leucines.
One possibility for such an ATF/CREB-like activator protein is GCN4, which can stimulate transcription in vivo through an ATF/CREB site (42) . However, in strains containing both gcn4 and acrl deletion alleles, the level of his3 transcription is similar to that observed in acrl deletion strains (Fig. 8) . Similarly, activation through the ATF/CREB site in the context of the gall TATA element is largely independent of GCN4 (Table 2) . Finally, disruption of YAP1, which encodes a bZIP protein that binds the related AP-1 site (34), has no effect on his3 levels in ACR1 wild-type and mutant strains.
cAMP-dependent protein kinases play a critical role in regulating the activities of some mammalian ATF/CREB proteins (14, 15, 40) as well as yeast ADR1 (7) . To assess whether disruption of the cAMP signaling pathway in yeast cells leads to altered levels of transcription mediated through ATF/CREB sites, we inactivated BCYI (52), a gene encoding the regulatory subunit of the three cAMP-dependent protein kinases, TPK1, TPK2, and TPK3 (53) . As shown in Fig. 8 , transcription from the his3-303 promoter appears to be very slightly elevated (twofold when normalized to the DEDJ internal control RNA) in a strain containing a bcyl::URA3 disruption allele.
Biochemical identification of ATF/CREB-like proteins distinct from ACR1. We had demonstrated previously that yeast cell extracts contain multiple ATF/CREB-like DNAbinding activities that can be distinguished by chromatography on heparin-agarose (42) . To determine whether these activities were distinct from that of ACR1, we examined chromatographic fractions from an acrl deletion strain for ATF/CREB activities by the electrophoretic mobility shift assay. Two major species that bind to an ATF/CREB site ( Fig. 9) This genetic argument is reinforced by the biochemical identification of two chromatographically distinct DNAbinding activities with ATF/CREB-like specificity. As these DNA-binding activities are observed in extracts prepared from acrl strains under conditions in which GCN4 expression is extremely low (20, 51) , these activities represent as-yet-uncharacterized biochemical species. We cannot determine whether the two activities represent the products of different genes or whether either of them is equivalent to ATF/CREB-like DNA-binding activities that have been ob- served by other laboratories (26, 30) . Although we are hesistant to ascribe transcriptional properties to these activities, it seems extremely likely that at least one of them represents the ATF/CREB-like activator(s) that we have detected through genetic means.
The above considerations define DNA-binding and transcriptional activities that interact with ATF/CREB sites. By analogy with mammalian cells, it is likely that proteins possessing these activities are conventional members of the ATF/CREB family with highly conserved bZIP domains. If so, heterodimeric interactions among ACR1, GCN4, and these putative ATF/CREB proteins may increase the complexity of the transcriptional response through ATF/CREB sites. However, it is possible that the proteins defined by our genetic and biochemical experiments are structurally unrelated to conventional ATF/CREB proteins. Nature of the repression by ACR1. ACR1 appears to repress transcription by at least two distinct mechanisms (Fig. 10) . One mechanism involves competition between ACR1 and transcriptional activators for ATF/CREB sites. Competition between ACR1 and putative ATF/CREB proteins explains why ATF/CREB sites are poor upstream activating sequences, and competition between ACR1 and GCN4 accounts for the low levels of transcription from the his3-303 promoter during amino acid starvation. As expected for a direct competition mechanism, transcriptional output is highly sensitive to changes in the intracellular concentration of repressor and/or activator proteins. For example, heterozygous ACRI/acrl diploids are less sensitive to AT than their homozygous ACRI/ACRI counterparts, indicating that a twofold reduction in ACR1 concentration reduces repression efficiency. This competition mechanism is analogous to the situation in mammalian cells, in which CREM antagonizes basal and cAMP-stimulated transcription mediated through ATF/CREB sites by CREB (12) .
Alternatively, ACR1 can repress transcription mediated by heterologous promoter elements. For example, constitutive his3 transcription is unaffected by mutations or deletions of the GCN4 binding site but is severely repressed by ACR1 when an ATF/CREB site is located between the poly(dA). poly(dT) upstream promoter element and the TATA region (42). As initially described for the Escherichia coli LexA repressor (4), this repression may simply reflect promoter interference caused by ACR1 binding between the critical promoter elements for constitutive his3 transcription. However, deletion of as few as 13 amino acids from the C terminus of a truncated ACR1 derivative destroys repressor activity in vivo without impairing DNA-binding activity in vitro. This result suggests that a domain outside the DNAbinding region may be required for repressor function, although we cannot exclude the trivial possibility that these protein derivatives with C-terminal deletions are unstable or not localized to the nucleus. Further analysis of the regulatory interactions at ATF/CREB sites in yeast cells will require biochemical and mutational analyses of ACR1 as well as identification and characterization of the gene(s) encoding the ATF/CREB-like transcriptional activator(s).
